Medical
Life Sciences
Information Communication
Environment
Nanotechnology / Materials
Energy
Manufacturing Technology
Social Infrastructure
Frontier
Innovative anemia therapy: Development of new anemia drugs targeting the novel mechanism of erythropoiesis
update：2020/06/16
- Features and Uniqueness
-
- Strong points
- Anemia is a very prevalent disease. Nevertheless, an effective therapy is yet to be discovered. Erythropoietin is effective only for those with renal dysfunction. We have found that inhibition of an enzyme for epigenetic regulation results in a prominent increase of erythropoiesis, pointing to a new target for anemia therapy. We have also generated a new, cell-based assay system for the enzymatic activity and carried out small molecule screening.
- Collaboration with industry partners
- We are seeking a collaboration to accelerate the development of new anemia drugs based on these findings. Together we will advance the development of the candidate molecules currently identified as well as conduct further screening of larger chemical space for better candidates and/or for drug repositioning.
- Keywords
Researchers
Graduate School of Medicine
Kazuhiko Igarashi, Professor
Doctor of Medicine
